Prof. Dr. FATİH EREN

Yayın Ağı

Makaleler 102

1. Enhancing Hepatocellular Carcinoma Surveillance: Comparative Evaluation of AFP, AFP-L3, DCP and Composite Models in a Biobank-Based Case-Control Study

DEMİRTAŞ C. Ö., Akin S., YILMAZ KARADAĞ D., YILMAZ İ. T., Ciftci U., Huseynov J., et al.

Cancers , cilt.17, sa.14, 2025 (SCI-Expanded, Scopus)

2. Type 2 diabetes risk among master swimmers: a case–control study

ÇELİK Z. M., İSLAMOĞLU A. H., SABUNCULAR G., EREN F., ÖZÜAK A., AKTAÇ Ş.

Nutrire , cilt.50, sa.1, 2025 (Scopus)

3. Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial

Karahan T. O., Akyuz E. Y., Karadag D. Y., Yılmaz Y., Eren F.

LIFE-BASEL , cilt.15, sa.5, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

4. N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma

Hasturk B., Avsar T., Ozbas S., Yilmaz B. K., Eren F.

MOLECULAR BIOLOGY , cilt.58, sa.6, ss.1280-1292, 2024 (SCI-Expanded, Scopus)

5. Production of platelet-rich plasma (PRP)-enriched scaffolds for bone tissue regeneration with 3D printing technology

Arslan Tut T., Cesur S., Şahin A., Eren F., Gündüz O.

European Polymer Journal , cilt.219, 2024 (SCI-Expanded, Scopus)

6. A therapeutic approach for the hepatitis C virus: in silico design of an antisense oligonucleotide-based candidate capsid inhibitor

Hasturk B., Eren F.

Virus Genes , cilt.60, sa.5, ss.446-454, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Turkish population in HBV related hepatocellular carcinoma

BİRCAN KADIOĞLU D., DEMİRTAŞ C. Ö., PİRİM D., Gündüz F., EREN F.

Hepatology forum , cilt.5, ss.106-112, 2024 (ESCI, Scopus, TRDizin)

8. Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B?

Demirtaş C. Ö., Eren F., Yılmaz D., Özdoğan O. C., Gunduz F.

Journal of gastrointestinal and liver diseases : JGLD , cilt.33, sa.2, ss.203-211, 2024 (SCI-Expanded, Scopus)

9. The pleiotropic approach to coronavirus disease-19 pathogenesis: The impact of liver diseases associated host genetic variants

ŞAHİN E., DAĞ A., EREN F., EREN F.

Hepatology forum , cilt.5, sa.2, ss.93-96, 2024 (ESCI, Scopus, TRDizin)

10. Analysis of microbiota profile and nutritional status in male professional football players

Kenger E. B., EREN F., Ozlu T., Gunes F. E.

The Journal of sports medicine and physical fitness , cilt.63, sa.11, ss.1235-1243, 2023 (SCI-Expanded, Scopus)

11. Relationship Between Nutritional Status, Anthropometric Measurements and Dietary Inflammatory Index in Professional Football Players

Kenger E. B., EREN F., GÜNEŞ F. E.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.13, sa.1, ss.143-149, 2023 (ESCI, TRDizin)

12. Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis

Sakallı Kani A., Ozercan A., Kani H. T., Eren F., Sayar K., Yılmaz Y.

Hepatology Forum , cilt.4, sa.3, ss.123-128, 2023 (Scopus) Sürdürülebilir Kalkınma

13. The International Standards for Neurological Classification of Spinal Cord Injury: Classification Accuracy and Challenges

Snider B. A., EREN F., Reeves R. K., Rupp R., Kirshblum S. C.

TOPICS IN SPINAL CORD INJURY REHABILITATION , cilt.29, sa.1, ss.1-15, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma

14. Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals.

Eren F., Kaya E., Yilmaz Y.

European journal of gastroenterology & hepatology , cilt.34, ss.98-103, 2022 (SCI-Expanded, Scopus)

15. The role of myocardial performance index and Nt-proBNP levels as a marker of heart dysfunction in nonalcoholic cirrhotic patients

TOKAY TARHAN S., Yilmaz Enc F., EREN F., FAK A. S., Ozdogan O.

MARMARA MEDICAL JOURNAL , cilt.35, sa.1, ss.10-16, 2022 (ESCI, Scopus, TRDizin)

16. The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease

Bayram H. M., EREN F., Gunes F. E.

HEPATOLOGY FORUM , cilt.2, sa.3, ss.128-136, 2021 (ESCI, Scopus)

17. Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening.

Yilmaz Y., Kaya E., Eren F.

Alimentary pharmacology & therapeutics , cilt.52, ss.1759-1760, 2020 (SCI-Expanded, Scopus)

18. **Evaluation of the Association between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study**

Demirci A. F., Demirtas C. O., Eren F., Yilmaz D., Keklikkiran Ç., Ozdogan O. C., et al.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , cilt.29, sa.4, ss.617-622, 2020 (SCI-Expanded, Scopus)

19. Effect of carbon dioxide versus room air insufflation on post-colonoscopic pain: A prospective, randomized, controlled study.

Gündüz F., Kani H., Chang S., Akdeniz E., Eren F., Yılmaz Y., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.31, ss.676-680, 2020 (SCI-Expanded, Scopus, TRDizin)

20. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study

Jafarov F., Kaya E., Bakir A., Eren F., Yilmaz Y.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.32, ss.642-649, 2020 (SCI-Expanded, Scopus)

21. The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases

Kaya E., Bakır A., Eren F., Yılmaz Y.

Hepatology Forum , cilt.1, sa.1, ss.8-13, 2020 (Scopus)

22. NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?

Yılmaz Y., Eren F.

ANGIOLOGY , cilt.71, ss.83-84, 2020 (SCI-Expanded, Scopus)

23. Analysis of 24-Hour Heart Rate Variability among Panic Disorder Patients without Previous Drug Treatment and Comorbid Disorders

Gunduz N., Akpinar Aslan E., EREN F., Sodan Turan H., Ozturk M., Tural U.

TURK PSIKIYATRI DERGISI , cilt.30, sa.4, ss.236-244, 2019 (SSCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

24. Potential clinical variants detected in mitochondrial DNA D-loop hypervariable region I of patients with non-alcoholic steatohepatitis

Hasturk B., Yilmaz Y., Eren F.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.18, ss.463-475, 2019 (SCI-Expanded, Scopus)

25. Comments on "The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease"

Yılmaz Y., Eren F.

SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES , cilt.29, sa.6, ss.548, 2019 (SCI-Expanded, Scopus)

26. Transient elastography for assessing severe hepatic fibrosis in diabetic patients with nonalcoholic fatty liver disease: definitions matter

Yilmaz Y., Eren F.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.31, sa.12, ss.1601-1602, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease

Yilmaz Y., Eren F.

ATHEROSCLEROSIS , cilt.290, ss.222-223, 2019 (SCI-Expanded, Scopus)

28. The relationship between internet addiction and eating attitudes and obesity related problems among university students

Gunduz N., GÖKÇEN O., EREN F., Erzincan E., Timur O., Turan H., et al.

KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY , cilt.22, sa.3, ss.266-275, 2019 (ESCI, Scopus, TRDizin)

29. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology

YILMAZ Y., EREN F.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.31, sa.1, ss.43-46, 2019 (SCI-Expanded, Scopus)

30. THE SEQUENCE ANALYSIS OF NEW MITOCHONDRIALGENE, MOTS-C, IN PATIENTS WITH THE NON-ALCOHOLICSTEATOHEPATITIS

Önal O., Eren F., Yılmaz D., Göçmen T., Yılmaz Y.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , cilt.6, ss.135, 2018 (SCI-Expanded, Scopus)

31. Development of multiplex single base primer extension assay for the detection of potential association between MTNR1B gene polymorphisms and NASH

Yılmaz D., Eren F., Göçmen T., Yılmaz Y.

Journal Of Biotechnology , cilt.280, ss.76, 2018 (SCI-Expanded, Scopus)

32. Nonalcoholic steatohepatitis and gut microbiota: Future perspectives on probiotics in metabolic liver diseases

YILMAZ Y., EREN F.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, sa.5, ss.327-328, 2017 (SCI-Expanded, Scopus, TRDizin)

33. Corrigendum to "The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF" [Int. J. Pharm. 478 (2015) 147-154].

Şalva E., Turan S., Eren F., Akbuğa J.

International journal of pharmaceutics , cilt.520, ss.297, 2017 (SCI-Expanded, Scopus)

34. Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis.

Ozen G., Deniz R., Eren F., Erzik C., Unal A., Yavuz S., et al.

The open rheumatology journal , cilt.11, ss.1-9, 2017 (Scopus)

35. The association of nonalcoholic fatty liver disease with genetic polymorphisms: A multicenter study

Uygun A., Ozturk K., Demirci H., Oztuna A., Eren F., Kozan S., et al.

European Journal of Gastroenterology and Hepatology , cilt.29, ss.441-447, 2017 (SCI-Expanded, Scopus)

36. Associations of IL23R, BMP6 and PTGS1 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis

Ozen G., Deniz R., EREN F., ERZİK C., Unal A. U., Aydin S. Z., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

37. Bactericidal Permeability Increasing Protein Gene Polymorphism is Associated with Inflammatory Bowel Diseases in the Turkish Population

CAN G., Akin H., Ozdemir F. T., Can H., Yilmaz B., EREN F., et al.

SAUDI JOURNAL OF GASTROENTEROLOGY , cilt.21, sa.4, ss.239-244, 2015 (SCI-Expanded, Scopus)

38. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease

ERGELEN R., Akyuz U., Aydin Y., EREN F., YILMAZ Y.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.27, sa.6, ss.667-671, 2015 (SCI-Expanded, Scopus)

39. ASSOCIATIONS OF ERAP1, IL23R AND PTGER4 POLYMORPHISM WITH RADIOGRAPHIC SEVERITY OF ANKYLOSING SPONDYLITIS

Ozen G., Deniz R., Eren F., Erzik C., Aydin S. Z., Inanc N., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.501, 2015 (SCI-Expanded, Scopus)

40. A Systems Genetics Approach to Dyslipidemia in Children and Adolescents

White M. J., EREN F., AĞIRBAŞLI D., Chen J., Hu T., Moore J. H., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.19, sa.4, ss.248-259, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. SHBG Gene Polymorphism (rs1799941) Associates with Metabolic Syndrome in Children and Adolescents

White M. J., EREN F., AĞIRBAŞLI D., Williams S. M., Agirbasli M.

PLOS ONE , cilt.10, sa.2, 2015 (SCI-Expanded, Scopus)

42. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1 alpha and VEGF

ŞALVA E., Turan S., EREN F., Akbuga J.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.478, sa.1, ss.147-154, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation

Deniz R., Ozen G., Yilmaz-Oner S., Alibaz-Oner F., Erzik C., Aydin S. Z., et al.

Lupus , cilt.24, sa.7, ss.705-711, 2015 (SCI-Expanded, Scopus)

44. Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5

Gullu G., Peker İ., Haholu A., EREN F., Kucukodaci Z., Gulec B., et al.

GENETICS AND MOLECULAR BIOLOGY , cilt.38, sa.1, ss.21-29, 2015 (SCI-Expanded, Scopus)

45. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects

Yonal O., EREN F., YILMAZ Y., ATUĞ Ö., Over H. H.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.6, ss.639-643, 2014 (SCI-Expanded, Scopus, TRDizin)

46. The Frequency and the Effects of 21-Hydroxylase Gene Defects in Congenital Adrenal Hyperplasia Patients

Kirac D., GÜNEY A. İ., Akcay T., GÜRAN T., ULUCAN K., Turan S., et al.

ANNALS OF HUMAN GENETICS , cilt.78, sa.6, ss.399-409, 2014 (SCI-Expanded, Scopus)

47. A comparison of FibroMeter (TM) NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease

Aykut U. E., Akyuz U., Yesil A., EREN F., Gerin F., ERGELEN R., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.11, ss.1343-1348, 2014 (SCI-Expanded, Scopus)

48. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease

YILMAZ Y., EREN F.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.26, sa.11, ss.1292-1295, 2014 (SCI-Expanded, Scopus)

49. Investigation of the Therapeutic Efficacy of Codelivery of psiRNA-Vascular Endothelial Growth Factor and pIL-4 into Chitosan Nanoparticles in the Breast Tumor Model

ŞALVA E., Turan S., Kabasakal L., Alan S., ÖZKAN N., EREN F., et al.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.103, sa.3, ss.785-795, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Frequency and Disease Severity of Familial Mediterranean Fever (FMF) Related MEFV Gene Mutations Among Ankylosing Spondylitis Patients

TUFAN A., AYDIN S. Z., EREN F., ATAGÜNDÜZ M. P.

Türkiye Klinikleri Tip Bilimleri Dergisi , cilt.34, ss.223-230, 2014 (Scopus)

51. Factitious disorder and factitious disorder by proxy comorbidity: a case report

EREN F., Oguz N., Yildirim F., Dilbaz N.

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.15, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

52. Multi-Locus Candidate Gene Analyses of Lipid Levels in a Pediatric Turkish Cohort: Lessons Learned on LPL, CETP, LIPC, ABCA1, and SHBG

Agirbasli M., EREN F., AĞIRBAŞLI D., White M. J., Williams S. M.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.17, sa.12, ss.636-645, 2013 (SCI-Expanded, Scopus)

53. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging

Yegin E. G., Siykhynnbayev A., EREN F., Bekiroglu N., ÖZDOĞAN O. C.

ANNALS OF HEPATOLOGY , cilt.12, sa.6, ss.915-925, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women

SÜNBÜL M., EREN F., NACAR C., Agirbasli M.

CARDIOLOGY JOURNAL , cilt.20, sa.3, ss.287-293, 2013 (SCI-Expanded, Scopus)

55. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., et al.

DIGESTIVE AND LIVER DISEASE , cilt.45, sa.1, ss.58-62, 2013 (SCI-Expanded, Scopus)

56. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back

YILMAZ Y., ÇOLAK Y., Kurt R., Senates E., EREN F.

TUMORI , cilt.99, sa.1, ss.10-16, 2013 (SCI-Expanded, Scopus)

57. Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis

YILMAZ Y., EREN F.

CLINICA CHIMICA ACTA , cilt.414, ss.154-157, 2012 (SCI-Expanded, Scopus)

58. Hepatic expression and serum levels of syndecan 1 (CD 138) in patients with nonalcoholic fatty liver disease

YILMAZ Y., EREN F., ÇOLAK Y., Senates E., ÇELİKEL Ç., Imeryuz N.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.47, sa.12, ss.1488-1493, 2012 (SCI-Expanded, Scopus)

59. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

Eren F., Kurt R., Ermis F., Atuğ Ö., Imeryuz N., Yılmaz Y.

Clinical Biochemistry , cilt.45, ss.655-658, 2012 (SCI-Expanded, Scopus)

60. Local Delivery of Chitosan/VEGF siRNA Nanoplexes Reduces Angiogenesis and Growth of Breast Cancer In Vivo

Salva E., KABASAKAL L., EREN F., ÖZKAN N., Cakalagaoglu F., Akbuga J.

NUCLEIC ACID THERAPEUTICS , cilt.22, sa.1, ss.40-48, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population

Alahdab Y., Eren F., Giral A., Gunduz F., Kedrah A. E., Atug O., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , cilt.24, sa.1, ss.27-30, 2012 (SCI-Expanded, Scopus)

62. Alterations in Serum BDNF Levels in Early Alcohol Withdrawal and Comparison with Healthy Controls

Cavus S. Y., Dilbaz N., Darcin A. E., EREN F., Kaya H., Kaya O.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.22, sa.3, ss.210-215, 2012 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

63. Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degeneration

YILMAZ Y., Kurt R., EREN F., Imeryuz N.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , cilt.71, sa.8, ss.631-636, 2011 (SCI-Expanded, Scopus)

64. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis

YILMAZ Y., EREN F., Ayyildiz T., Colak Y., Kurt R., Senates E., et al.

CLINICA CHIMICA ACTA , cilt.412, ss.2296-2299, 2011 (SCI-Expanded, Scopus)

65. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

Yilmaz Y., Yonal O., Eren F., Atug O., Hamzaoglu H. O.

Journal of Crohn's and Colitis , cilt.5, sa.5, ss.402-406, 2011 (SCI-Expanded, Scopus)

66. Serum galectin-3 levels in patients with nonalcoholic fatty liver disease

YILMAZ Y., EREN F., Kurt R., Yonal O., Polat Z., Senates E., et al.

CLINICAL BIOCHEMISTRY , cilt.44, sa.12, ss.955-958, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Multimarker Strategies for Detecting NASH and NASH-Related Fibrosis: Promises and Caveats

YILMAZ Y., Kurt R., EREN F.

OBESITY SURGERY , cilt.21, sa.8, ss.1316-1317, 2011 (SCI-Expanded, Scopus)

68. Reply to Aydin et al: "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?"

Yılmaz Y., Eren F.

Metabolism: Clinical and Experimental , cilt.60, 2011 (SCI-Expanded, Scopus)

69. The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease

Agirbasli M., Sumerkan M. C., EREN F., AĞIRBAŞLI D.

HEART AND VESSELS , cilt.26, sa.4, ss.457-463, 2011 (SCI-Expanded, Scopus)

70. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease

YILMAZ Y., Kurt R., Gurdal A., ÖZEN ALAHDAB Y., Yonal O., Senates E., et al.

ATHEROSCLEROSIS , cilt.217, sa.1, ss.125-129, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy

Agirbasli M., Eren M., EREN F., Murphy S. B., Serdar Z. A., SEÇKİN GENÇOSMANOĞLU D., et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , cilt.32, sa.1, ss.59-63, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. Effects of lecithin: Cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels

Agirbasli D., Cirakoglu B., EREN F., Sumerkan M., Aksoy S., Aral C., et al.

JOURNAL OF CLINICAL LIPIDOLOGY , cilt.5, sa.3, ss.152-158, 2011 (SCI-Expanded, Scopus)

73. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease

Aktas B., YILMAZ Y., EREN F., Yonal O., Kurt R., Alandab Y., et al.

METABOLISM-CLINICAL AND EXPERIMENTAL , cilt.60, sa.4, ss.544-549, 2011 (SCI-Expanded, Scopus)

74. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease

Akin H., Tahan G., Ture F., EREN F., ATUĞ Ö., Tahan V., et al.

JOURNAL OF CROHNS & COLITIS , cilt.5, sa.1, ss.14-18, 2011 (SCI-Expanded, Scopus)

75. Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease

Yılmaz Y., Eren F., Yonal O., Polat Z., Bacha M., Kurt R., et al.

Disease Markers , cilt.31, ss.205-210, 2011 (SCI-Expanded, Scopus)

76. Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease

Yılmaz Y., Yonal O., Eren F., Kurt R., Celikel C. A., Ozdogan O., et al.

Clinical Chemistry and Laboratory Medicine , cilt.49, ss.93-97, 2011 (SCI-Expanded, Scopus)

77. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

Yılmaz Y., Yonal O., Kurt R., Alahdab Y., Eren F., Ozdogan O., et al.

Scandinavian Journal of Gastroenterology , cilt.46, ss.91-97, 2011 (SCI-Expanded, Scopus)

78. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B

EREN F., YILMAZ Y., Kose S., Ozdemir F. T., Yonal O., Kurt R., et al.

CLINICA CHIMICA ACTA , cilt.411, ss.2029-2032, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History

EREN F., AKKİPRİK M., ATUĞ Ö., Sonmez O., Tahan G., Ozdemir F., et al.

PATHOLOGY & ONCOLOGY RESEARCH , cilt.16, sa.4, ss.563-568, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Epidemiology and diagnosis of hepatitis B in the mediterranean region and elsewhere

Tözün N., Ersoy Ö., EREN F., Tahan V.

NATO Science for Peace and Security Series A: Chemistry and Biology , ss.239-260, 2010 (Scopus) Sürdürülebilir Kalkınma

81. Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease

Yılmaz Y., Yonal O., Kurt R., Oral A. Y., Eren F., Ozdogan O., et al.

Scandinavian Journal of Clinical and Laboratory Investigation , cilt.70, ss.541-546, 2010 (SCI-Expanded, Scopus)

82. The Effect of Lecithin: Cholesterol Acyltransferase Genotypes, Enzyme Levels and Activity on High Density Lipoprotein Levels In Turkish Population

Agirbasli D., Agirbasli M., Eren F., Sumerkan M., Aral C., Aksoy S., et al.

CIRCULATION , cilt.122, sa.21, 2010 (SCI-Expanded, Scopus)

83. Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease

YILMAZ Y., Eren F., Yonal O., Kurt R., Aktas B., ÇELİKEL Ç., et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , cilt.40, sa.10, ss.887-892, 2010 (SCI-Expanded, Scopus)

84. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.

Ozdemir F., Tiftikci A., Sancak S., Eren F., Tahan V., Akın H., et al.

Journal of gastrointestinal cancer , cilt.41, ss.185-9, 2010 (SCI-Expanded, Scopus)

85. Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats

Tahan G., Eren F., Tarcin O., Akin H., Tahan V., Sahin H., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.21, sa.3, ss.287-292, 2010 (SCI-Expanded, Scopus, TRDizin)

86. Chitosan/Short Hairpin RNA Complexes for Vascular Endothelial Growth Factor Suppression Invasive Breast Carcinoma

Salva E., KABASAKAL L., EREN F., Cakalagaoglu F., ÖZKAN N., Akburga J.

OLIGONUCLEOTIDES , cilt.20, sa.4, ss.183-190, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. C-KIT Gene Polymorphism in Achalasia

Alahdab Y. O., EREN F., Gunduz F., Kedrah A. E., YILMAZ Y., Atug O., et al.

GASTROENTEROLOGY , cilt.138, sa.5, 2010 (SCI-Expanded, Scopus)

88. Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?

Tahan V., Ozaras R., Karaca C., Uraz S., EREN F., Danalioglu A., et al.

HEPATO-GASTROENTEROLOGY , cilt.56, ss.1425-1428, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats

Canbakan B., Akin H., Tahan G., Tarcin O., Eren F., Atug O., et al.

ANNALS OF HEPATOLOGY , cilt.8, sa.3, ss.234-240, 2009 (SCI-Expanded, Scopus)

90. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats

Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin O., et al.

JOURNAL OF PINEAL RESEARCH , cilt.46, sa.4, ss.401-407, 2009 (SCI-Expanded, Scopus)

91. Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis

Tiftikci A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.

ARCHIVES OF MEDICAL RESEARCH , cilt.40, sa.4, ss.294-298, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. GLUCAGON LIKE PEPTIDE-2 DO NOT ALTER SEVERITY OF CARRAGENEAN INDUCED KNEE ARTHRITIS BUT HASTENS ACCOMPANYING INTESTINAL INFLAMMATION IN RATS

KOCAKAYA O., Deniz M., Ozdemir Z. N., Memi G., Bas E., ÇELİKEL Ç., et al.

JOURNAL OF PHYSIOLOGICAL SCIENCES , cilt.59, ss.540, 2009 (SCI-Expanded, Scopus)

93. MICROSATELLITE INSTABILITY IN THE INFLAMED AND NON-NEOPLASTIC COLONIC MUCOSA IN ULCERATIVE COLITIS

ATUĞ Ö., AKKİPRİK M., EREN F., TIFTIKCI A., Ozdemir F. T., Asicioglu F., et al.

MARMARA MEDICAL JOURNAL , cilt.22, sa.1, ss.12-18, 2009 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

94. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARγ) gene in inflammatory bowel disease

ATUĞ Ö., Tahan V., EREN F., Tiftikci A., Imeryuz N., Hamzaoglu H. O., et al.

Journal of Gastrointestinal and Liver Diseases , cilt.17, sa.4, ss.433-437, 2008 (SCI-Expanded, Scopus)

95. Is there a role for adipocytokines on the effect of anti-TNF treatment in an experimental model of colitis?

Yapali S., Deniz M., EREN F., Imeryuz N., Celikel Ç., Ozkan N., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded, Scopus)

96. Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity

Uraz S., Tahan V., Aygun C., EREN F., Unluguzel G., YÜKSEL M., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.53, sa.4, ss.1071-1077, 2008 (SCI-Expanded, Scopus)

97. Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis

Tahan V., Eren F., Avsar E., Yavuz D., Yuksel M., Emekli E., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.52, sa.12, ss.3465-3472, 2007 (SCI-Expanded, Scopus)

98. The effects of N-Acetylcysteine on bile duct ligation-induced liver fibrosis in rats

Tahan G., Tarcin O., Tahan V., Eren F., Gedik N., Sahan E., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.52, sa.12, ss.3348-3354, 2007 (SCI-Expanded, Scopus)

99. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death

Imeryuz N., Tahan V., Sonsuz A., Eren F., Uraz S., Yuksel M., et al.

JOURNAL OF HEPATOLOGY , cilt.47, sa.6, ss.851-859, 2007 (SCI-Expanded, Scopus)

100. Peptide nucleic acids for the detection of YMDD in chronic hepatitis B.

Eren F., Tahan V., Ozdemir F., Akin H., Tozun N.

Journal of gastrointestinal and liver diseases : JGLD , cilt.15, ss.320-1, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey.

Ozdemir F., Duman D., Ertem D., Avşar E., Eren F., Ozdoğan O. C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.16, ss.183-7, 2005 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

102. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.

Tahan V., Avsar E., Karaca C., Uslu E., Eren F., Aydin S., et al.

World journal of gastroenterology , cilt.9, ss.2325-7, 2003 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 44

1. VALIDATION OF MICROBIAL SIGNATURE FOR ADVANCED FIBROSIS IN A GLOBAL MULTI-ETHNIC COHORT OF MASLD

Smirnova E., YILMAZ Y., EREN F., Muthiah M., Oliveira C., Siddiqui M., et al.

The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, (Özet Bildiri)

2. VALIDATION OF AND MECHANISTIC INSIGHTS ON A BILE ACID SIGNATURE OF FIBROSIS PROGRESSION IN METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS

Smirnova E., Kang J., YILMAZ Y., EREN F., Zhou H., Mirshahi F., et al.

The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, (Özet Bildiri)

3. “The gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Hepatocellular Carcinoma”

BİRCAN KADIOĞLU D., DEMİRTAŞ C. Ö., PİRİM D., Gündüz F., EREN F.

EASL Liver Cancer Summit, Estoril, Portekiz, 20 Nisan 2023, ss.134-135, (Özet Bildiri)

4. MDR1 Gen Polimorfizminin Kolon Kanseri Hastalrında Ekspresyon ve Klinikopatolojik Özelliklerle İlişkisi

Özden G., UPRAK T. K., ATALAY V., EREN F.

17. Türk Kolon ve Rektum Cerrahisi Kongresi, Türkiye, 9 - 13 Nisan 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

5. İn Vitro Nonalkolik Yağlı Karaciğer Modelinde Mitokondriyal Kökenli MOTS-c Peptidinin Hastalık Etyopatogenezi Üzerine Etkileri

Göçmen T., Eren F., Yılmaz D., Yılmaz Y.

15. Ulusal Hepato Gastroenteroloji Kongresi, Antalya, Türkiye, 10 - 14 Ekim 2018, ss.63-64, (Özet Bildiri)

6. Preliminary evidence of an association between mtDNA D-loop polymorphisms and the clinicopathological features of nonalcoholic steatohepatitis

Hasturk B., Yılmaz Y., Eren F.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri)

7. Nonalcoholic steatohepatitis: modulation of histological phenotype by the missense Thr174Met (rs4762) polymorphism of the angiotensinogen (AGT) gene

EREN F., Balcilar H., Yilmaz D., Toker T., YILMAZ Y., Hasturk B.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri)

8. Mitochondrial DNA control region nucleotide variations in non-alcoholic steatohepatitis

Hasturk B., Yılmaz Y., Eren F.

European Biotechnology Congress, Dubrovnik, Hırvatistan, 25 - 27 Mayıs 2017, cilt.256, (Özet Bildiri)

9. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study

UYGUN A., öztürk k., demirci h., öztuna a., EREN F., KOZAN S., et al.

JOURNAL OF HEPATOLOGY, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, ss.148, (Özet Bildiri)

10. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study

Uygun A., Ozturk K., Demirci H., Oztuna A., Eren F., Kozan S., et al.

International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, (Özet Bildiri)

11. Türk toplumunda alkolik olmayan yağlı karaciğer hastalığının genetik polimorfizm ile ilişkisi çok merkezli kontrollü çalışma

UYGUN A., öztürk k., DEMİRCİ H., öztuna a., EREN F., YILMAZ Y., et al.

33.Ulusal gastronetroloji haftası, Antalya, Türkiye, 22 - 27 Kasım 2016, (Özet Bildiri)

12. İrritabl barsak sendromlu hastalarda yüksek laktoz intolerans sıklığı

hasanov r., ÖZEN ALAHDAB Y., EREN F., GÜNDÜZ F., YILMAZ Y., AYKUT U. E.

33.Ulusal gastroenetroloji haftası, Türkiye, 22 - 27 Kasım 2016, (Özet Bildiri)

13. Bactericidal permeability increasing protein has no effect on remission of ulcerative colitis

EREN F., eroğlu k., Banzragch M., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.

The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016

14. MT ND5 gene variants have both protective and risk factor for inflammatory bowel disease

Eren F., Safarova C., Gündüz F., Özen Alahdab Y., Kurt R., Yılmaz Y., et al.

The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016, (Özet Bildiri)

15. The effect of combination treatment with melatonin and rapamycin on intracellular lipid accumulation in human HepG2 cells

Yaşar Y. Z., Hastürk B., Yılmaz Y., Eren F.

European Human Genetics Conference 2016, Barcelona, İspanya, 21 Mayıs 2016 - 24 Mayıs 2017, ss.143, (Özet Bildiri)

16. Ülseratif Kolitin ÜK Hastalık Aktivitesi Bakterisidal Permeabilite Arttırıcı Protein BPI Düzeyi ile İlişkilidir

EREN F., EROĞLU K., MUNKHTSETSEG B., ALAHDAB Y. Ö., KURT R., YILMAZ Y., et al.

32. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 29 Kasım 2015

17. Ülseratif kolitin hastalık aktivitesi bakterisidal permeabilite arttırıcı protein BPI düzeyi ile ilişkilidir

EREN F., eroğlu k., banzragch m., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.

32. Ulusal Gastroenetroloji Haftası, Türkiye, 25 - 29 Kasım 2015

18. The anti inflammatory and neuroprotective effects of erythropoietin on hyperbilirubinemic newborn rats

YAMAN A., KOLGAZİ M., MEMİŞOĞLU A., BAHADIR E., ŞİRVANCI S., YEGEN B., et al.

12th World Congress of Perinatal Medicine, 3 - 04 Kasım 2015, (Özet Bildiri)

19. EFFECTS OF ATORVASTATIN, PIOGLITAZONE AND ERYTHROPOIETIN ON THE EXPRESSIONS OF IRON TRANSPORT MOLECULES IN PHLEBOTOMY-ENHANCED ANEMIA OF RATS WITH CHRONIC KIDNEY DISEASE

KOÇ M., Ozdemir Z., EREN F., Haklar G. G., YEGEN B.

52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London, Kanada, 28 - 31 Mayıs 2015, cilt.30, (Özet Bildiri)

20. Mitokondriyal Nikotinamid Adenin Dinükleotid Dehidrogenaz 5 (ND5) geni 12361A/G nükleotid varyasyonu Nonalkolik Yağlı Karaciğer Hastalığında (NAYKH) Koruyucu mu, Risk Faktörü mü?

Eren F., Orkun M., Akkiprik M., Kılıç K., Güner E., Erzik C., et al.

31. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 30 Kasım 2014, ss.370, (Özet Bildiri)

21. Mitokondriyal DNA Displacement-Loop (D-Loop) 16189 Timin/Sitozin Polimorfizmlerinin Non Alkolik Yağlı Karaciğer Hastalarındaki Klinik Önemi ve Yeni RFLP Paterni

Eren F., Güner E., Akkiprik M., Kılıç K., Erzik C., Akın H., et al.

31. Ulusal Gastroentereloji Haftası, Antalya, Türkiye, 25 - 30 Kasım 2014, ss.370, (Özet Bildiri)

22. FAMILIAL MEDITERRANEAN FEVER GENE (MEFV) MUTATIONS AND DISEASE SEVERITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE); IMPLICATIONS ON THE ROLE OF THE E148Q MEFV ALLELE ON INFLAMMATION

Deniz R., Ozen G., Yilmaz-Oner S., Alibaz-Oner F., EREN F., Alhan O., et al.

15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, ss.320, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Meme kanserinde miR-140 ve IGFBP-5 ekspresyon düzeyleri arasındaki ilişkinin araştırılması

GÜLLÜ AMURAN G., Peker İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.

XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2013, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

24. miR-193b ekspresyon düzeyi ile ERalfa ve IGFBP5 ilişkisinin meme kanserindeki rolü

Peker İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.

XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Türkiye, 27 - 30 Ekim 2013, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

25. A Safely Treatment Modality in Wilson's Disease: Liver Transplantation.

TOSUN M., Aydinli B., Ozturk G., Ertekin V., KISAOĞLU A., Ozogul B., et al.

19th Annual International Congress of the International-Liver-Transplantation-Society (ILTS), Sydney, Avustralya, 12 - 15 Haziran 2013, (Özet Bildiri)

26. Co-Delivery of VEGF siRNA and IL-4 into Chitosan Nanoparticles in Breast Tumor Model of Rat

ŞALVA E., ÖZBAŞ TURAN S., KABASAKAL L., EREN F., Alan S., ÖZKAN N., et al.

16th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Utah, Amerika Birleşik Devletleri, 15 - 18 Mayıs 2013, cilt.21, (Özet Bildiri)

27. A BIOMARKER PANEL WITH HIGH SENSITIVITY AND SPECIFICITY FOR NONALCOHOLIC STEATOHEPATITIS IDENTIFIED BY SUPPORT VECTOR MACHINE

Yilmaz Y., Eren F.

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)

28. HEPATIC EXPRESSION AND SERUM LEVELS OF SYNDECAN 1 (CD138) IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

Yilmaz Y., Eren F., Colak Y., Senates E., Celikel C. A., Imeryuz N.

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)

29. Meme Kanserinde miR-140 ve IGFBP-5 Ekspresyon Düzeyleri Arasındaki İlişkinin Araştırılması

GÜLLÜ AMURAN G., Peker İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.

IV. Multidisipliner Kanser Araştırma Kongresi, Bursa, Türkiye, 13 - 16 Aralık 2012, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

30. Meme Kanserinde miR-140 ve IGFBP-5 Ekspresyon Düzeyleri Arasındaki İlişkinin Araştırılması

GÜLLÜ AMURAN G., PEKER EYÜBOĞLU İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.

IV. Multidisipliner Kanser Araştırma Kongresi, Türkiye, 13 - 16 Aralık 2012, (Özet Bildiri) Sürdürülebilir Kalkınma

31. miR-193b EKSPRESYON DÜZEYİ ile ERalfa ve IGFBP5 İLİŞKİSİNİN MEME KANSERİNDEKİ ROLÜ

Peker İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.

IV. Multidisipliner Kanser Araştırma Kongresi, Bursa, Türkiye, 13 - 16 Aralık 2012, (Özet Bildiri) Sürdürülebilir Kalkınma

32. miR-193b EKSPRESYON DÜZEYİ ile ERalfa ve IGFBP5 İLİŞKİSİNİN MEME KANSERİNDEKİ ROLÜ

PEKER EYÜBOĞLU İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.

IV. Multidisipliner Kanser Araştırma Kongresi, Türkiye, 12 - 14 Aralık 2012, (Özet Bildiri) Sürdürülebilir Kalkınma

33. The Association Between Bactericidal Permeability Increasing Protein (BPI) Gene Polymorphism and Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn's Disease's Subphenotypes

Can G., Akin H., Ozdemir F. T., Eren F., Atug O., Unsal B., et al.

Conference on Digestive Disease Week 2011, Illinois, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2011, cilt.140, (Özet Bildiri)

34. Association of MDRI Gene and Helicobacter pylori in the Development of Gastric Cancer and Gastritis

Eren F., Imeryuz N., Bas E., Ozkan N., Ozdemir F. T., Yilmaz Y., et al.

Conference on Digestive Disease Week 2011, Illinois, Amerika Birleşik Devletleri, 7 - 10 Mayıs 2011, cilt.140, (Özet Bildiri) Sürdürülebilir Kalkınma

35. GG Genotype of SHBG Gene rs1799941 Polymorphism May Indicate Genetic Predisposition to Metobolic Syndrome among Postmenopausal Women

SÜNBÜL M., EREN F., AĞIRBAŞLI M. A.

EPI-NPAM, ATLANTA, Amerika Birleşik Devletleri, 22 - 25 Mart 2011, ss.228-229 Sürdürülebilir Kalkınma

36. SERUM LEVELS OF OSTEOPROTEGERIN IN THE SPECTRUM OF NONALCOHOLIC FATTY LIVER DISEASE

Yilmaz Y., Yonal O., Kurt R., Eren F., Imeryuz N., Kalayci C., et al.

46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Berlin, Almanya, 30 Mart - 03 Nisan 2011, (Özet Bildiri) Sürdürülebilir Kalkınma

37. CIRCULATING LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF) AND ITS SOLUBLE RECEPTOR SVEGFR-1 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE

Yilmaz Y., Alahdab Y. O., Kurt R., Yonal O., Eren F., Kalayci C., et al.

46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Berlin, Almanya, 30 Mart - 03 Nisan 2011, (Özet Bildiri)

38. Chitosan Mediated VEGF shRNA Transfer for the Treatment of Breast Cancer

ŞALVA E., KABASAKAL L., Ozkan N., EREN F., Cakalagaoglu F., Akbuga J.

18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, ss.1411, (Özet Bildiri)

39. MEFV GENE MUTATIONS IN ANKYLOSING SPONDYLITIS: IMPACT ON RADIOGRAPHIC SEVERITY

TUFAN A., EREN F., AYDIN S. Z., DİRESKENELİ R. H., ATAGÜNDÜZ M. P.

Seventh International Congresson Spondyloarthropathies, Belçika, 7 - 09 Ekim 2010, cilt.28, ss.625, (Özet Bildiri)

40. MELATONIN AMELIORATES METHIONINE CHOLINE DEFICIENT DIET INDUCED NONALCOHOLIC STEATOHEPATITIS IN RATS

Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin Ö., et al.

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)

41. Prevalence and Genotype Identification of HPV Infection in a Population of Turkish Women

EREN F., Erenus M., BAŞ E., Ahiskali R., Yoldemir T.

98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Massachusetts, Amerika Birleşik Devletleri, 7 - 13 Mart 2009, cilt.89, (Özet Bildiri) Sürdürülebilir Kalkınma

42. Epidemiology and Diagnosis of Hepatitis B in the Mediterranean Region and Elsewhere

Tozun N., Ersoy O., EREN F., Tahan V.

NATO Advanced Research Workshop on Detection of Bacteria, Viruses, Parasites and Fungi, Perugia, İtalya, 18 - 21 Kasım 2008, ss.239-245, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

43. Association between Toll-like 4, cd14 polymorphisms and inflammatory bowel disease in Turkish population

Akin H., Oezdemir F. T., Atug O., Tahan G., Eren F., Baca B., et al.

Digestive Disease Week Meeting/109th Annual Meeting of the American-Gastroenterological-Association, California, Amerika Birleşik Devletleri, 17 - 22 Mayıs 2008, cilt.134, (Özet Bildiri)

44. Glucagon like peptide-1 (GLP-1) ameliorates methionine and choline deficient (MCD) diet induced nonalcoholic steotahepatitis by reducing tissue proinflammatory cytokines

Kedrah A. E., Deniz M., Eren F., Tahan V., Kurtel H., Celikel C., et al.

16th International Symposium on Regulatory Peptides, Hakone, Japonya, 31 Ağustos - 02 Eylül 2006, cilt.135, ss.135-136, (Özet Bildiri)

Kitaplar 5

Metrikler

Yayın

152

Yayın (WoS)

123

Yayın (Scopus)

102

Atıf (WoS)

1740

H-İndeks (WoS)

Atıf (Scopus)

1853

H-İndeks (Scopus)

Atıf (Scholar)

3127

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler